Protalix BioTherapeutics (PLX) EBITDA (2009 - 2026)
Protalix BioTherapeutics (PLX) posted EBITDA of $4.8 million for Q2 2026, up 272.7% from $1.29 million a year earlier but down 77.7% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Protalix BioTherapeutics was $24.59 million, up 162.9% year-over-year; for FY2025, it came in at -$4.04 million.
- In prior years, Protalix BioTherapeutics' EBITDA was $5.22 million in FY2024 (-55.2%), $11.65 million in FY2023, -$11.91 million in FY2022 and -$19.34 million in FY2021.
- Quarterly EBITDA has run from a low of -$5.45 million in Q4 2021 to a high of $21.55 million in Q1 2026 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was $21.55 million (Q1 2026), -$4.27 million (Q4 2025) and $2.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 4.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.47 Mn |
| Jun 30, 2026 | 4.80 Mn |
| Mar 31, 2026 | 21.55 Mn |
| Dec 31, 2025 | -4.27 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Dec 31, 2024 | 7.54 Mn |
| Sep 30, 2024 | 4.32 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -4.53 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -1.52 Mn |
| Jun 30, 2023 | 20.78 Mn |
| Mar 31, 2023 | -2.10 Mn |
| Dec 31, 2022 | -2.13 Mn |
| Sep 30, 2022 | -2.77 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -1.53 Mn |
| Dec 31, 2021 | -5.34 Mn |
API Access
Protalix BioTherapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();